GlassScriptPhysician profile
Robert Walter Carpenter
NPI 1174006928
$1,821.05
in general payments reported to CMS, 2019-2025
14 companies · $1,202 in 2025
The $1,202 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $463 · 2022: $156 · 2025: $1,202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $804 · Food and Beverage: $353 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $804.03 |
| Food and Beverage | $352.52 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,079.56 | 2025 | Intellis Adaptivestim |
| Collegium Pharmaceutical, INC. | $206.75 | 2021-2025 | Belbuca |
| Biodelivery Sciences International, INC. | $76.42 | 2021 | |
| Redhill Biopharma INC. | $70.50 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $53.85 | 2022 | |
| Amgen INC. | $53.69 | 2021-2022 | |
| Abbvie INC. | $52.75 | 2021 | |
| Grt US Holding, INC. | $45.00 | 2021 | |
| Emergent Biosolutions INC. | $45.00 | 2021 | |
| Averitas Pharma INC. | $36.63 | 2025 | Qutenza |
| Globus Medical, INC. | $34.37 | 2025 | Senza |
| Horizon Therapeutics Plc | $30.37 | 2021-2022 | |
| Pfizer INC. | $22.00 | 2025 | |
| Boston Scientific Corporation | $14.16 | 2025 | Entrada |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Carpenter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.